Guangzhou, China

Dongsheng Ni

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Zhaoke (Guangzhou) Ophthalmic Drug Company Limited. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dongsheng Ni. Retrieved from https://idiyas.com/inventor/dongsheng-ni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Dongsheng Ni

Introduction

Dongsheng Ni is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the area of drug purification processes. His work focuses on enhancing the quality and efficacy of pharmaceutical formulations.

Latest Patents

Dongsheng Ni holds a patent for a process of controlling the impurities of clindamycin hydrochloride. This invention provides a method for purifying clindamycin hydrochloride using two-phase high-performance liquid chromatography. The specific chromatographic conditions include a detection wavelength of 200-220 nm, a column temperature of 20-40°C, and a flow rate of 0.8-1 ml/min. The mobile phases used are a 0.025 mol/L potassium dihydrogen phosphate solution and acetonitrile, with gradient elution performed. This method effectively addresses the interference caused by excipients and allows for the simultaneous separation of multiple impurities. It also establishes a quality standard for impurities in such formulations.

Career Highlights

Dongsheng Ni is currently associated with Zhaoke (Guangzhou) Ophthalmic Drug Company Limited, where he continues to innovate in the field of ophthalmic pharmaceuticals. His expertise in drug formulation and purification has positioned him as a valuable asset to his company and the industry at large.

Collaborations

Throughout his career, Dongsheng Ni has collaborated with notable colleagues, including Jing Liu and Gang Li. These partnerships have fostered a collaborative environment that enhances the development of innovative pharmaceutical solutions.

Conclusion

Dongsheng Ni's contributions to the field of pharmaceuticals, particularly through his patented process for controlling impurities in clindamycin hydrochloride, highlight his role as an influential inventor. His work not only improves drug quality but also sets important standards in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…